TY  - JOUR

T1  - Targeting the adrenomedullin-2 receptor for the discovery and development of novel anti-cancer agents

JO  - Expert Opinion on Drug Discovery

PY  - 2022/06/22

AU  - Jailani ABA

AU  - Bigos KJA

AU  - Avgoustou P

AU  - Egan JL

AU  - Hathway RA

AU  - Skerry TM

AU  - Richards GO

ED  - 

DO  - DOI: 10.1080/17460441.2022.2090541

PB  - Informa UK Limited

SP  - 1

EP  - 10

Y2  - 2024/12/26

ER  -